Nutrition drink for undernourished people after joint replacement surgery for osteoarthritis
Tests Ensure supplements on blood markers in undernourished people after joint replacement.
Key facts
- Who runs it
- NYU Langone Health
- Where
- New York and Philadelphia, United StatesSee the 2 sites
- Trial code
- Registry title
- Oral Nutritional Optimization in Total Joint Arthroplasty
- Status
- Recruiting
- People taking part
- 72 people, planned
- Started
- 6 Jul 2021
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Ensure
- Record updated
- 30 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 55 to 95 who are planned for a first, elective hip or knee replacement and have blood tests showing poor nutrition.
- Age
- 55 to 95 years
- Sex
- All sexes
- Disease stage
- People planned for a first (primary), planned (elective) total hip or total knee replacement.
- Biomarker or test result
- At least one of these blood results: Serum Albumin ≤3.5 mg/dl, Pre-Albumin <15 mg/dl, or Transferrin <200 mg/dl.
Main reasons for not taking part
- Past joint infection (septic arthritis)
- Allergy to oral supplements, or unable to take them by mouth
- Protein malabsorption problems or eating disorders
- End stage kidney or liver disease
- Repeat (revision) surgery, non-elective surgery, hemiarthroplasty, or partial (unicompartmental) knee replacement
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Patient are current candidates for elective primary total hip and total knee arthroplasty
- Patients ≥55 years of age but ≤ 95
- Patients who meet at least one of the following three laboratory criteria for malnutrition:; TSerum Albumin: ≤3.5 mg/dl Pre-Albumin: <15 mg/dl Transferrin: <200 mg/dl
Who cannot take part
- Previous history of septic arthritis
- Revision surgery, non-elective surgery, hemiarthroplasty, and unicompartmental knee arthroplasty
- Allergy to oral supplementation
- Protein malabsorption syndromes
- Eating disorders
- End stage renal and hepatic disease
- Inability to consume oral supplementation
Where in United States
- NYU Langone HealthNew York, United StatesContact: Daniel WarenTaking people
- Rothman Orthopedic InstitutePhiladelphia, United StatesContact: Alicia ReyesTaking people
About the trial
What the trial wants to find out
The purpose of this study is to determine the effect on hematological markers of nutritional intervention on nutritionally deficient patients following total joint replacement surgery.
The 2 groups in the trial
- Nutritional supplementationTreatment being tested
Given Ensure Max Protein Nutrition shake 2 weeks before surgery and continued 2 weeks after surgery.
Treatment: Ensure
- No Nutritional supplementationNo study treatment, for comparison
Treatment as usual
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Oral Nutritional Optimization in Total Joint Arthroplasty
- Plain-language title
- Nutrition drink for undernourished people after joint replacement surgery for osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 30 October 2026